Comparison of Dual- versus Triple-Targeted Drug Therapy for Patients with Left-To-Right Shunt Congenital Heart Disease-Associated Pulmonary Arterial Hypertension
Combination targeted therapy is effective for patients with left-to-right shunt CHD-PAH, regardless of closure status. Among patients not eligible for closure, triple-targeted therapy demonstrated superior efficacy compared to dual-targeted therapy.
Authors
- Lifan Yang (ORCID: https://orcid.org/0000-0003-0581-1964)
- Dandan Chen (ORCID: https://orcid.org/0000-0002-7690-4837)
- Hao Li (ORCID: https://orcid.org/0000-0002-8644-0263)
- Junbo Ge (ORCID: https://orcid.org/0000-0002-9360-7332)
- Wenzhi Pan
Institutions
- Sun Yat-sen University (CN)
- Fudan University (CN)
- Shanghai Xuhui Central Hospital (CN)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Shanghai Clinical Research Center (CN)
- YangPu Geriatric Hospital (CN)
Publication Details
- Journal
- Cardiology
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1159/000548907
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00